NASDAQ:MOTS Motus GI (MOTS) Stock Price, News & Analysis $0.0001 0.00 (0.00%) As of 06/12/2026 12:13 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsSEC FilingsTrendsBuy This Stock About Motus GI Stock (NASDAQ:MOTS) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Motus GI alerts:Sign Up Key Stats Today's Range$0.0001▼$0.000150-Day Range N/A52-Week Range$0.00▼$0.10Volume50,010 shsAverage Volume7,640 shsMarket Capitalization$576.90P/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Motus GI Holdings, Inc. is a clinical-stage medical technology company developing advanced endoscopic solutions for the minimally invasive diagnosis and treatment of gastrointestinal disorders. The company’s platform is designed to improve procedural control, stability and precision during complex therapeutic interventions in the GI tract, such as tissue resection, hemostasis and suturing. By integrating electromechanical instruments into a single-use device, Motus GI aims to enhance clinical efficiency and patient outcomes compared with conventional flexible endoscopes. The company’s lead product candidate is an electromechanical endoscopy system built around a multifunctional, disposable module that delivers stable instrument control and intuitive maneuverability. The platform incorporates proprietary motorized elements and disposable accessory channels, enabling physicians to perform a broad spectrum of advanced therapeutic procedures through natural orifice access. Motus GI has secured intellectual property covering instrument actuation, device assembly and system control software, and is conducting pre-commercial and clinical validation studies in the United States. Headquartered in California, Motus GI serves hospitals, ambulatory surgery centers and endoscopy clinics across North America. Its management team brings extensive experience in medical device development, regulatory affairs and commercialization for minimally invasive surgical technologies. The company continues to advance its clinical and regulatory programs, positioning its platform for future market entry in the United States and select international markets.AI Generated. May Contain Errors. Read More Receive MOTS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Motus GI and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MOTS Stock News HeadlinesMOTS Motus GI Holdings, Inc. - Seeking AlphaJuly 2, 2025 | seekingalpha.comMotus GI Hldgs (OTC:MOTS) Stock, Insider Trading ActivityDecember 13, 2024 | benzinga.comTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no debate, no vote, one executive order. Gold tripled within three years and climbed 20x over the following decade. Trump holds that same executive authority today, and his advisors are openly saying a reversal is on the table. There are two ways this plays out - both move gold in the same direction. A free briefing breaks down exactly what Nixon did, why Trump is positioned to act, and how to move your 401k into gold before any announcement - tax free.June 15 at 1:00 AM | Reagan Gold Group (Ad)Motus GI Hldgs (OTC:MOTS) Stock, Short Interest ReportOctober 6, 2024 | benzinga.comMotus GI Hldgs (OTC:MOTS) Stock Quotes, Forecast and News SummaryOctober 6, 2024 | benzinga.comMotus GI annonce la démission de son conseil d'administration et l'arrêt de ses activitésJuly 31, 2024 | fr.investing.comMOTS Stock Earnings: Motus GI Hldgs Beats EPS, Misses Revenue for Q1 2024May 14, 2024 | msn.comMotus GI Reports First Quarter 2024 Financial Results and Provides Corporate UpdateMay 14, 2024 | finance.yahoo.comSee More Headlines MOTS Stock Analysis - Frequently Asked Questions How have MOTS shares performed this year? Motus GI's stock was trading at $0.0001 at the beginning of 2026. Since then, MOTS shares have increased by 0.0% and is now trading at $0.0001. How were Motus GI's earnings last quarter? Motus GI Holdings, Inc. (NASDAQ:MOTS) announced its quarterly earnings results on Friday, November, 12th. The company reported ($30.00) earnings per share for the quarter, meeting analysts' consensus estimates of ($30.00). The firm had revenue of $0.14 million for the quarter, compared to analysts' expectations of $0.12 million. When did Motus GI's stock split? Motus GI's stock reverse split on Thursday, November 2nd 2023.The 1-15 reverse split was announced on Wednesday, November 1st 2023. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, November 1st 2023. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split. When did Motus GI IPO? Motus GI (MOTS) raised $21 million in an initial public offering on Wednesday, February 14th 2018. The company issued 3,500,000 shares at $5.00-$7.00 per share. Piper Jaffray acted as the underwriter for the IPO and Oppenheimer & Co. was co-manager. How do I buy shares of Motus GI? Shares of MOTS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Motus GI own? Based on aggregate information from My MarketBeat watchlists, some other companies that Motus GI investors own include Inovio Pharmaceuticals (INO), Matinas Biopharma (MTNB), NIO (NIO), Tesla (TSLA), Bionano Genomics (BNGO), Pfizer (PFE). Company Calendar Last Earnings11/12/2021Today6/15/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryMedical Equipment Current SymbolNASDAQ:MOTS CIK1686850 Webwww.motusgi.com Phone(954) 541-8000Fax954-541-8265Employees30Year Founded2010Profitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$319 thousand Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book Value$1.74 per share Price / Book0.00Miscellaneous Outstanding Shares5,769,000Free Float5,749,000Market Cap$576.90 OptionableNot Optionable Beta0.82 Social Links 7 Stocks That Will Be Magnificent in 2026Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free Report This page (NASDAQ:MOTS) was last updated on 6/15/2026 by MarketBeat.com Staff. From Our PartnersThe 1934 playbookIn 1934, a legal government maneuver transferred billions in wealth overnight. Most Americans never saw it com...American Alternative | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredIs SpaceX really worth 1.78 Trillion?With SpaceX approaching a near-$2 trillion valuation, most investors are focused on the IPO itself - but analy...InvestPub | SponsoredHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | SponsoredSpaceX is chump change compared to Elon’s $20T ‘iPhone’Early Apple investors saw peak gains as high as 7,537% after the iPhone launched. Now, multiple insider source...StocksToTrade | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Motus GI Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Motus GI With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
